Canaccord Genuity resumed coverage on Sesen Bio
$SESN
Biotechnology: Pharmaceutical Preparations
Health Care
Canaccord Genuity resumed coverage of Sesen Bio with a rating of Buy
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/16/2021 | Buy → Neutral | HC Wainwright & Co. |
HC Wainwright & Co. downgraded Sesen Bio from Buy to Neutral
Canaccord Genuity resumed coverage of Sesen Bio with a rating of Buy and set a new price target of $7.00
HC Wainwright reiterated coverage of Sesen Bio with a rating of Buy and set a new price target of $8.00 from $2.25 previously